Archive
See details of previously published customer updates from our Health products team.
Showing 41 - 60 of 133 results
See details of previously published customer updates from our Health products team.
Read about an ANSTO scientist and their work to prepare for a school project or interview.
To enable the production of nuclear medicine, ANSTO operates manufacturing, processing and distribution facilities in Sydney.
A selection of research highlights, instrument news and technical developments for scientists.
A long-standing collaboration led biomedical researchers from the University of Sydney has recently achieved success with the recent announcement of an innovative bone implant that significantly reduces rejection and inflammation.
The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.
ANSTO has collaborated on a study assessing the impact of the commonly-used food additive titanium dioxide (TiO2) on gut microbiota and inflammation.
You are invited to submit to the various awards from ANSTO, User Advisory Committee (UAC) and Australian Neutron Beam User Group (ANBUG).
You are invited to submit to the various awards from ANSTO and the User Meeting 2024 organising committee.
By submitting a proposal for Merit Access to ANSTO’s Biosciences, Centre for Accelerator Science, Isotope Tracing, Nuclear Stewardship or the Vivarium capabilities, you are agreeing to the following Terms and Conditions. These Terms and Conditions apply to external merit researchers, scientific collaborators and partners unless there is a specific agreement in place between ANSTO and the home institution of the Principal Investigator.
Supporting healthcare professionals in Australia with easy-to-access resources related to ANSTO’s Gentech® Generator.
This month ANSTO is opening its doors to 11 talented young people from across Australia as the two-year Graduate Program kickstarts.
ANSTO scientist, Dr Klaus Wilcken of the Centre for Accelerator Science, used cosmogenic nuclide dating to determine the ages of layered sand and gravel samples, in which seven footprints of the flightless bird, the moa, were found on the South Island in New Zealand in 2019.
ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.
In space, without the protection of the magnetosphere, the type and dose of radiation is considerably different to what is naturally experienced on earth. However, it is the secondary particles of lower energies created when galactic and cosmic radiation interacts with shielding that is of concern for astronauts.